Aurobindo Pharma’s CuraTeQ Biologics reported successful trial results for BP16, a bone treatment drug. BP16 showed bioequivalence to Prolia in trials with 204 volunteers.
Share it
Related Article
Open an Account in less than 1 Min.
Need help? Call us
+919769768500
Services
Company
Get in touch
- +919769768500
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Marketrade Private Limited